Huntington’s Disease Treatment Market Overview, Growth Opportunities and Forecast to 2030
Huntington’s Disease Treatment Market
Huntington Disease is a brain disorder that causes
uncontrolled movements, emotional problems, and loss of thinking ability.
Huntington disease usually appears in a person at a age of 30 or 40. Early
symptoms can include irritability, depression, small involuntary movements,
poor coordination, and trouble learning new information or making decisions.
The individuals suffering from this disorder may have trouble in walking,
speaking, and swallowing. People with this disorder also experience decline in
thinking and reasoning abilities. Individuals suffering with this huntington
disease usually live about 15 to 20 years after signs and symptoms begin.
Huntington’s Disease Treatment Market is expected to reach USD 373.31
Million rise steadily at a CAGR of 19.1% during forecast period of 2022-2030.
Huntington’s
disease treatment market is expected to grow in the near
future due to rise in incidence of genetic diseases, increasing research and
development activities to develop drugs that can be used for treatment of this
disorder and developing healthcare sector. Key players in market are
making their position in many developing countries due to the FDI policies
regulated within the pharmaceuticals industry in such countries with increasing
consumer demands towards maintaining aesthetic appearance is also driving the
market for global huntington’s disease treatment market.
However, some factors that can hamper the growth of this market are
rising side effect associated with drugs, lack of awareness regarding genetic
disorder and alternative treatment plan.
Some of the Huntington’s
Disease Treatment Market Players are engaged in new launches of drug
and devices so as to maintain the strategic collaborations to hold its market
position
Some of the
key players in the global huntington’s disease treatment market
are AmpliPhi Biosciences Corp, Ceregene Inc., Lundbeck, Prana
Biotechnology Limited, Cortex Pharmaceuticals Inc., Vertex Pharmaceuticals
Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena
Biotech, Raptor Pharmaceutical, Pfizer, Palobiofarma, Omeros Ipsen, Valeant
Pharmaceuticals International Inc., Alnylam Pharmaceuticals Inc., Teva
Pharmaceutical Industries Ltd.
Regional Analysis
America is expected to hold the
highest market share for huntington market treatment and the reason being many market players are
engaged in development of new drug product innovation. Whereas increasing
awareness of genetic disorders and rising healthcare expenditure by the
government and rise in incidence of these genetic disease are some of the
factors responsible for growth of market in this region
Europe is expected to be the
second largest market in the globe owing to the increasing aging population,
increasing prevalence of huntington’s disease, focus on aesthetic appearance,
increasing research base. Whereas rise in susceptible immune compromised
patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be
the fastest growing market owing to the changing lifestyle, increase in
population, increasing healthcare expenditure by government are some of the
factor responsible for market growth in this region.
Middle East and Africa is
expected to account for the smallest share in the global huntington’s disease
treatment market due to underdeveloped healthcare sector, lack of technical
knowledge, and poor medical facilities.
Segment Analysis
Global huntington’s disease treatment market is
segmented into drug type, treatment and end-users. On basis of drug type the
global huntington disease treatment market is segmented into tetrabenazine,
deutetrabenazine, selective serotonin reuptake inhibitor (SSRI),
chlorpromazine,haloperidol, risperidone, olanzapine, clozapine another drug
type.
Based on treatment the market is further segmented
into two types such as symptomatic therapy and disease-modifying therapy.On
basis of end-users the market is further segmented into hospital, clinics,
retail pharmacies, online pharmacies and others.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment